Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: John M. Gelnieau who wrote (19986)	3/22/1999 9:02:00 PM
From: blankmind	Read Replies (1) \| Respond to of 23519

- Luckily VVUS's new CFO is holding the line on expenses; and making the current revenue stream positive for the Company. - So when the gene threrapy, alibra, or the Female drug comes out, not to mention a merger, stock price is off to the races.

To: John M. Gelnieau who wrote (19986)	3/22/1999 9:21:00 PM
From: VLAD	Respond to of 23519

John, I believe that your thinking is the same thinking many here have been thinking for a long long time now. Seems like we have all been waiting for things to turn around and most of us will wait for hell to freeze over before we give away our shares at these nonsensical prices. As you know these small cap NASDAQ stocks can fluctuate to extremely irrational low and high levels depending on the developments at hand. The positives we have been discussing here over the past months are all materializing--slowly in the usual Vivus way but they are happening one after another. Question is, what do the market manipulators do when Vivus inks a domestic partner??? I bet they run the sucker back up to ridiculously over valuated levels as in 1997. Our time will come--sooner or later.